Works matching IS 2160763X AND DT 2014 AND VI 3 AND IP 6


Results: 13
    1
    2
    3
    4
    5
    6
    7

    A randomized, double blind, dose escalation, first time in human study to assess the safety, tolerability, pharmacokinetics, and antiviral activity of single doses of GSK2485852 in chronically infected hepatitis C subjects.

    Published in:
    Clinical Pharmacology in Drug Development, 2014, v. 3, n. 6, p. 439, doi. 10.1002/cpdd.142
    By:
    • Wilfret, David A.;
    • Walker, Jill;
    • Voitenleitner, Christian;
    • Baptiste‐Brown, Sharon;
    • Lovern, Mark;
    • Kim, Joseph;
    • Adkison, Kimberly;
    • Shotwell, Brad;
    • Mathis, Amanda;
    • Moss, Lee;
    • Lee, Daniel;
    • Yu, Lou;
    • Gan, Jianjun;
    • Spaltenstein, Andrew
    Publication type:
    Article
    8
    9
    10
    11
    12
    13